148 related articles for article (PubMed ID: 30238973)
1. Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
Chattopadhyay S; Sud A; Zheng G; Yu H; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Int J Cancer; 2018 Nov; 143(10):2449-2457. PubMed ID: 30238973
[TBL] [Abstract][Full Text] [Related]
2. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
[TBL] [Abstract][Full Text] [Related]
3. Second primary cancers in non-Hodgkin lymphoma: Family history and survival.
Chattopadhyay S; Zheng G; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Int J Cancer; 2020 Feb; 146(4):970-976. PubMed ID: 31054153
[TBL] [Abstract][Full Text] [Related]
4. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
6. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
[TBL] [Abstract][Full Text] [Related]
7. Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?
Chattopadhyay S; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
J Invest Dermatol; 2020 Jan; 140(1):48-55.e1. PubMed ID: 31288011
[TBL] [Abstract][Full Text] [Related]
8. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M
Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432
[TBL] [Abstract][Full Text] [Related]
10. Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden.
Chattopadhyay S; Zheng G; Sud A; Yu H; Sundquist K; Sundquist J; Försti A; Hemminki A; Houlston R; Hemminki K
Lancet Haematol; 2018 Aug; 5(8):e368-e377. PubMed ID: 30075833
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer survivors: Risk and mortality in second primary cancers.
Chattopadhyay S; Zheng G; Hemminki O; Försti A; Sundquist K; Hemminki K
Cancer Med; 2018 Nov; 7(11):5752-5759. PubMed ID: 30277023
[TBL] [Abstract][Full Text] [Related]
13. Second cancers and causes of death in patients with testicular cancer in Sweden.
Zhang L; Hemminki O; Chen T; Yu H; Zheng G; Chattopadhyay S; Försti A; Sundquist K; Sundquist J; Hemminki K
PLoS One; 2019; 14(3):e0214410. PubMed ID: 30921367
[TBL] [Abstract][Full Text] [Related]
14. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
15. Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Clin Epidemiol; 2020; 12():857-864. PubMed ID: 32821171
[TBL] [Abstract][Full Text] [Related]
16. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
[TBL] [Abstract][Full Text] [Related]
17. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
18. Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer.
Chattopadhyay S; Zheng G; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
Br J Dermatol; 2020 Sep; 183(3):488-494. PubMed ID: 31853941
[TBL] [Abstract][Full Text] [Related]
19. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
